Zacks Investment Research · Aug 21, 2023
THRN vs. HQY: Which Stock Should Value Investors Buy Now?
THRN vs. HQY: Which Stock Is the Better Value Option?
TH
NASDAQ · THRN
Thorne HealthTech, Inc.
Consumer Defensive · Packaged Foods
$10.19
Down-$0.01 (-0.10%)
Updated Aug 14, 2026, 8:16 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 550.63M
- P/E ratio
- 34.3
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 84.69K
- Avg. volume
- 253.52K
Price performance
THRN price history
1M range · 0 trading sessions · Daily adjusted prices
THRN does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest THRN news
The latest Smart Investors Daily articles mentioning THRN.
Stock researchCompany · Overview
THRN research
Overview
Company profile and research snapshot.
Company profile
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $5.75
- Implied upside
- —
- Analysts
- 10
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 11, 2023 | Evercore ISI Group | Neutral | — |
| Aug 30, 2023 | TD Cowen | Market Perform | — |
| Aug 11, 2023 | Canaccord Genuity | Buy | — |
| Apr 4, 2023 | Canaccord Genuity | Buy | — |
| Nov 17, 2022 | Canaccord Genuity | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 17, 2023
Top 5 Risk Off Stocks That Should Keep You Up At Night
The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70. Here’s the latest list of major overbought players in this sector. Jupiter Wellness, Inc. (NASDAQ: JUPW) Jupiter Wellness reported efficacy results from clinical study for its NoStingz Topical Jellyfish protection sunscreen. The company’s stock has a 52-week high of $1.64. . RSI Value: 70.25 JUPW Price ...
The Motley Fool · Aug 10, 2022
Thorne HealthTech, Inc. (THRN) Q2 2022 Earnings Call Transcript
THRN earnings call for the period ending June 30, 2022.
Seeking Alpha · Jun 5, 2022
Thorne HealthTech: Poised To Outperform Other Nutraceutical Companies
Thorne HealthTech (THRN) is one of the best stock options in nutraceutical/supplements market in my opinion. Click here to know why.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
